מאקליבן 400 מג 5 מל

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ixtrih issa

Ingredjent attiv:

AMOXICILLIN AS TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM

Disponibbli minn:

NOVARTIS ISRAEL LTD

Kodiċi ATC:

J01CA04

Għamla farmaċewtika:

אבקה להכנת תרחיף

Kompożizzjoni:

AMOXICILLIN AS TRIHYDRATE 400 MG / 5 ML; CLAVULANIC ACID AS POTASSIUM 57 MG / 5 ML

Rotta amministrattiva:

פומי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

SANDOZ GmbH, AUSTRIA

Grupp terapewtiku:

AMOXICILLIN

Żona terapewtika:

AMOXICILLIN

Indikazzjonijiet terapewtiċi:

For the treatment of lower respiratory tract infections, otitis media infections, sinusitis infections, acute pharyngitis, skin and soft tissues infections and urinary tract infections caused by beta-lactamase producing organisms which are susceptible to Amoxycillin + Potassium clavulanate and are resistant to other beta-lactam antibiotics.

Data ta 'l-awtorizzazzjoni:

2015-03-31

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ingliż 14-09-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Għarbi 14-09-2022